NewAmsterdam Pharma Company N.V. - NAMS

SEC FilingsOur NAMS Tweets

About Gravity Analytica

Recent News

  • 09.30.2025 - Stifel 2025 Virtual CardioMetabolic Forum
  • 09.30.2025 - Stifel 2025 Virtual CardioMetabolic Forum
  • 09.24.2025 - NewAmsterdam Pharma to Present at the Stifel 2025 Virtual Cardiometabolic Forum
  • 09.24.2025 - NewAmsterdam Pharma to Present at the Stifel 2025 Virtual Cardiometabolic Forum
  • 09.05.2025 - 2025 Wells Fargo Healthcare Conference
  • 09.05.2025 - 2025 Wells Fargo Healthcare Conference
  • 09.04.2025 - Cantor Global Healthcare Conference 2025
  • 09.04.2025 - Cantor Global Healthcare Conference 2025
  • 09.03.2025 - Citi's 2025 Biopharma Back to School Conference
  • 09.03.2025 - Citi's 2025 Biopharma Back to School Conference

Recent Filings

  • 09.30.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
  • 09.17.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.10.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.10.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.09.2025 - 144 Report of proposed sale of securities
  • 09.05.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.03.2025 - 144 Report of proposed sale of securities
  • 09.02.2025 - 8-K Current report
  • 09.02.2025 - EX-99.1 EX-99.1